175 related articles for article (PubMed ID: 36130928)
21. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer.
Zhang M; Yang L; Hou L; Tang X
Bioengineered; 2021 Dec; 12(2):9239-9250. PubMed ID: 34806925
[TBL] [Abstract][Full Text] [Related]
22. MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma.
Lu F; Mu B; Jin G; Zhu L; Mu P
Oncol Res; 2022 May; 29(1):1-10. PubMed ID: 34937609
[TBL] [Abstract][Full Text] [Related]
23. A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
Montemurro L; Raieli S; Angelucci S; Bartolucci D; Amadesi C; Lampis S; Scardovi AL; Venturelli L; Nieddu G; Cerisoli L; Fischer M; Teti G; Falconi M; Pession A; Hrelia P; Tonelli R
Cancer Res; 2019 Dec; 79(24):6166-6177. PubMed ID: 31615807
[TBL] [Abstract][Full Text] [Related]
24. The long non-coding RNA GAS5 differentially regulates cell cycle arrest and apoptosis through activation of BRCA1 and p53 in human neuroblastoma.
Mazar J; Rosado A; Shelley J; Marchica J; Westmoreland TJ
Oncotarget; 2017 Jan; 8(4):6589-6607. PubMed ID: 28035057
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
26.
Maeshima R; Moulding D; Stoker AW; Hart SL
Nucleic Acid Ther; 2020 Aug; 30(4):237-248. PubMed ID: 32240058
[TBL] [Abstract][Full Text] [Related]
27. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
28. LncRNA Snhg1-driven self-reinforcing regulatory network promoted cardiac regeneration and repair after myocardial infarction.
Li M; Zheng H; Han Y; Chen Y; Li B; Chen G; Chen X; Huang S; He X; Wei G; Xu T; Feng X; Liao W; Liao Y; Chen Y; Bin J
Theranostics; 2021; 11(19):9397-9414. PubMed ID: 34646377
[No Abstract] [Full Text] [Related]
29. Long non-coding RNA NHEG1/hsa-miR-665/HMGB1 axis is involved in the regulation of neuroblastoma progression.
Zhang Y; Hu Y; Pan A; He L; Wang J; Zhou F; Lei Y; Wang Y
Bioengineered; 2021 Dec; 12(2):11584-11596. PubMed ID: 34889712
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA SNHG1 predicts a poor prognosis and promotes colon cancer tumorigenesis.
Yang H; Wang S; Kang YJ; Wang C; Xu Y; Zhang Y; Jiang Z
Oncol Rep; 2018 Jul; 40(1):261-271. PubMed ID: 29749530
[TBL] [Abstract][Full Text] [Related]
31. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.
Zhao Z; Shelton SD; Oviedo A; Baker AL; Bryant CP; Omidvarnia S; Du L
J Exp Clin Cancer Res; 2020 Feb; 39(1):41. PubMed ID: 32087738
[TBL] [Abstract][Full Text] [Related]
32. Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCN.
Zhang Q; Zhang Q; Jiang X; Ye Y; Liao H; Zhu F; Yan J; Luo L; Tian L; Jiang C; Chen Y; Liang X; Sun Y
Theranostics; 2019; 9(4):986-1000. PubMed ID: 30867811
[No Abstract] [Full Text] [Related]
33. Long non-coding RNA SNHG1/microRNA-195-5p/Yes-associated protein axis affects the proliferation and metastasis of gastric cancer via the Hippo signaling pathway.
Cheng F; Wang L; Yi S; Liu G
Funct Integr Genomics; 2022 Oct; 22(5):1043-1055. PubMed ID: 35819551
[TBL] [Abstract][Full Text] [Related]
34. Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):329-335. PubMed ID: 29424921
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1.
Wu Y; Zhu B; Yan Y; Bai S; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
Mol Oncol; 2021 May; 15(5):1584-1596. PubMed ID: 33641229
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of the long non-coding RNA SNHG1 predicts poor prognosis, promotes cell proliferation and invasion, and reduces apoptosis in glioma.
Wang Q; Li Q; Zhou P; Deng D; Xue L; Shao N; Peng Y; Zhi F
Biomed Pharmacother; 2017 Jul; 91():906-911. PubMed ID: 28501778
[TBL] [Abstract][Full Text] [Related]
37. RNA-Binding Proteomics Reveals MATR3 Interacting with lncRNA SNHG1 To Enhance Neuroblastoma Progression.
Yang TW; Sahu D; Chang YW; Hsu CL; Hsieh CH; Huang HC; Juan HF
J Proteome Res; 2019 Jan; 18(1):406-416. PubMed ID: 30516047
[TBL] [Abstract][Full Text] [Related]
38. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
[TBL] [Abstract][Full Text] [Related]
39. Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.
Lee AC; Shih YY; Zhou F; Chao TC; Lee H; Liao YF; Hsu WM; Hong JH
J Mol Med (Berl); 2019 Mar; 97(3):325-339. PubMed ID: 30612140
[TBL] [Abstract][Full Text] [Related]
40. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.
Shohet JM; Ghosh R; Coarfa C; Ludwig A; Benham AL; Chen Z; Patterson DM; Barbieri E; Mestdagh P; Sikorski DN; Milosavljevic A; Kim ES; Gunaratne PH
Cancer Res; 2011 Jun; 71(11):3841-51. PubMed ID: 21498633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
